Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Clinical trial NCT00003850 · COMPLETED

Trial details

NCT number: NCT00003850
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 1999-04-01
Primary completion: 2003-06-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.